Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan 14;83(1):125-129.
doi: 10.1292/jvms.20-0375. Epub 2020 Nov 25.

Successful treatment of elephant endotheliotropic herpesvirus infection in an Asian elephant (Elephas maximus) calf by oral acyclovir medication: Case report

Affiliations
Case Reports

Successful treatment of elephant endotheliotropic herpesvirus infection in an Asian elephant (Elephas maximus) calf by oral acyclovir medication: Case report

Siripat Khammesri et al. J Vet Med Sci. .

Abstract

Elephant endotheliotropic herpesvirus (EEHV) is a major cause of death in Asian elephant (Elephas maximus) calves. A 2-year, 11-month-old female, captive Asian elephant presented with facial edema and a mild fever. Blood samples were collected and showed EEHV1A positivity with a high viral load by real time PCR. Heterophil toxicity also was reported for the first time in this case. The calf was treated orally with acyclovir, 45 mg/kg tid for 28 days, which reduced the EEHV1A viral load to undetectable levels within 9 days and the calf survived. A successful outcome with oral acyclovir administration provides another and affordable option to treat EEHV hemorrhagic disease in Asian elephants, and one that is easier to administer in untrained calves.

Keywords: Asian elephant; acyclovir; elephant endotheliotropic herpesvirus (EEHV); heterophil toxicity; oral medication.

PubMed Disclaimer

Conflict of interest statement

We confirm there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Viral load of an elephant calf during elephant endotheliotropic herpesvirus1A-hemorrhagic disease (EEHV1A-HD) infection and treatment with oral acyclovir (45 mg/kg/d) for 28 days, Note log scale for viral loads. Undetectable viral load was showed in the dot at the baseline. The clinical signs were showed above the figure.
Fig. 2.
Fig. 2.
Heterophil left-shifting and toxicity with a monocyte and lymphocyte in a blood smear collected, ×40 objective (a, b). A band heterophil that lacked nuclear constrictions and smooth parallel nuclear walls (c, d, e) and a heterophil with moderate cytoplasmic basophilia, ×100 objective (f, g, h). Wright Giemsa stain.

Similar articles

Cited by

References

    1. Bentz B. G., Maxwell L. K., Erkert R. S., Royer C. M., Davis M. S., MacAllister C. G., Clarke C. R.2006. Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. J. Vet. Intern. Med. 20: 589–594. doi: 10.1111/j.1939-1676.2006.tb02901.x - DOI - PubMed
    1. Boonprasert K., Mahasawangku S., Angkawanish T., Jansittiwej S., Langkaphin W., Sombutputorn P., Bampenpol P., Mahanil W.2015. Endotheliotropic herpesvirus treatments in a wild orphan baby Asian elephant (Elephas maximus). In: 10th International Elephant Endotheliotropic Herpesvirus (EEHV) Workshop, Crowne Plaza River Oaks, Houston.
    1. Boonprasert K., Punyapornwithaya V., Tankaew P., Angkawanish T., Sriphiboon S., Titharam C., Brown J. L., Somgird C.2019. Survival analysis of confirmed elephant endotheliotropic herpes virus cases in Thailand from 2006 - 2018. PLoS One 14: e0219288. doi: 10.1371/journal.pone.0219288 - DOI - PMC - PubMed
    1. Brock A. P., Isaza R., Hunter R. P., Richman L. K., Montali R. J., Schmitt D. L., Koch D. E., Lindsay W. A.2012. Estimates of the pharmacokinetics of famciclovir and its active metabolite penciclovir in young Asian elephants (Elephas maximus). Am. J. Vet. Res. 73: 1996–2000. doi: 10.2460/ajvr.73.12.1996 - DOI - PMC - PubMed
    1. Colunga Biancatelli R. M. L., Berrill M., Marik P. E.2020. The antiviral properties of vitamin C. Expert Rev. Anti Infect. Ther. 18: 99–101. doi: 10.1080/14787210.2020.1706483 - DOI - PubMed

Publication types